Compare AKBA & STRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKBA | STRT |
|---|---|---|
| Founded | 2007 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 241.4M |
| IPO Year | 2014 | 1996 |
| Metric | AKBA | STRT |
|---|---|---|
| Price | $0.39 | $62.28 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | $3.92 | ★ $82.00 |
| AVG Volume (30 Days) | ★ 8.6M | 52.6K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.94 | 9.17 |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $439,195,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.46 |
| P/E Ratio | ★ N/A | $53.90 |
| Revenue Growth | N/A | ★ 5.24 |
| 52 Week Low | $0.54 | $57.01 |
| 52 Week High | $1.89 | $93.00 |
| Indicator | AKBA | STRT |
|---|---|---|
| Relative Strength Index (RSI) | 25.15 | 44.60 |
| Support Level | N/A | $58.18 |
| Resistance Level | $1.54 | $84.30 |
| Average True Range (ATR) | 0.07 | 2.55 |
| MACD | -0.01 | 0.34 |
| Stochastic Oscillator | 9.73 | 35.23 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
Strattec Security Corp designs automotive access company that designs and delivers safe, secure, and engineered access solutions for the automotive and mobility markets. Built on generations of access and security engineering expertise, partner closely with OEMs to create differentiated, system level access experiences for end consumers. Its product portfolio spans the access journey from Permission, enabling secure vehicle entry through advanced mechanical and electronic systems; to Motion, delivering effortless, reliable powered access that enhances everyday usability; and through to Hold, providing precision engineered latching solutions.